8
M. Valderrama et al. / Journal of Organometallic Chemistry 665 (2003) 7ꢁ12
/
2. Experimental
2.2.2. Synthesis of [(h5-C5Me5)MCl{h2-P,P?-
(Ph2P)2NMe}]I (MꢀRh 3, Ir 4)
/
A mixture of complex [(h5-C5Me5)MCl{h2-P,P?-
(Ph2P)2NH}]BF4 (0.18 mmol) and potassium tert-but-
oxide (20.2 mg; 0.18 mmol) in dry CH2Cl2 (20 ml) was
stirred at r.t. for 1 h. The solution was evaporated to
dryness and the solid residue extracted with C6H5CH3.1
To this solution, methyl iodide (1 ml; 16 mmol) was
added and the mixture was heated under reflux for 1 h.
The yellow solid formed was filtered, washed with Et2O
and dried under vacuum. Complex 3: Yield: 70 mg, 46%.
Anal. Found: C, 52.5; H, 4.7; N, 1.6. C35H38ClINP2Rh
2.1. General
All reactions were carried out under purified nitrogen
using Schlenk-tube techniques. Solvents were dried,
distilled, and stored under a nitrogen atmosphere. The
starting compounds [{(h5-C5Me5)MCl(m-Cl)}2] (Mꢀ
/
Rh, Ir) and [(h5-C5Me5)MCl{h2-P,P?-(Ph2P)2NH}]BF4
were prepared by published procedures [3b,7]. The
ligands NH(PPh2)2 and NMe(PPh2)2 were prepared
following the method of Wang et al. [8]. Elemental
analyses (C, H, N) were carried out with a Fisons EA
1108 microanalyzer. FTIR spectra were recorded on a
Bruker Vector-22 spectrophotometer using KBr pellets.
The NMR spectra were recorded on a Bruker AC-200P
spectrometer. Chemical shifts are reported in ppm
relative to SiMe4 (1H) and 85% H3PO4 (31P, positive
shifts downfield) as internal and external standards,
respectively.
1
requires: C, 52.6; H, 4.8; N, 1.8%. H-NMR (CDCl3,
4
23 8C): d 1.62 [t, 15H, C5Me5, J(PH)ꢀ
/
4.2 Hz], 2.9 [t,
3H, Me, 3J(PH)ꢀ
31P{1H}-NMR (CDCl3, 23 8C): d 66.7 [d, J(PRh)ꢀ
121.9 Hz]. FTIR (KBr, cmꢃ1): n(CH, aliphatic) 2936
CH3) 839 vs. Complex 4: Yield: 92 mg, 60%.
/
9.7 Hz], 7.3ꢁ
/
7.8 (m, 20H, Ph).
1
/
m, g(NÃ
/
Anal. Found: C, 47.8; H, 4.4; N, 1.7. C35H38ClIIrNP2
1
requires: C, 47.3; H, 4.3; N, 1.6%. H-NMR (CDCl3,
4
23 8C): d 1.70 [t, 15H, C5Me5, J(PH)ꢀ
/2.81 Hz], 2.93
3
[t, 3H, Me, J(PH)ꢀ
/
10.1 Hz], 7.20ꢁ
/
7.80 (m, 20H, Ph).
31P{1H}-NMR (CDCl3, 23 8C): d 33.5 [s]. FTIR (KBr,
cmꢃ1): n (CH, aliphatic) 2912, 2983 w, g(NÃ
vs.
/
CH3) 827
2.2. Preparation of complexes
2.2.3. Synthesis of [(h5-C5Me5)MCl{h2-P,P?-
(Ph2P)2NMe}]BF4 (MꢀRh 5, Ir 6)
The complexes could be prepared by either of the two
methods described below.
/
2.2.1. Synthesis of [(h5-C5Me5)MCl{h2-P,P?-
(Ph2P)2NMe}]Cl (MꢀRh 1, Ir 2)
/
To a solution of the binuclear complex [{(h5-
C5Me5)MCl(m-Cl)}2] (0.08 mmol; Rh, 50 mg; Ir, 64
mg) in C6H5CH3 (10 ml) was added a solution of
NMe(PPh2)2 (64 mg; 0.16 mmol) in C6H5CH3 (10 ml).
After stirring the mixture for 1 h at room temperature
(r.t.) the solution was concentrated to a small volume.
Yellow solids were obtained by addition of n-hexane.
Complex 1: Yield: 109 mg, 96%. Anal. Found: C, 59.0;
H, 5.1; N, 2.0. C35H38Cl2NP2Rh requires: C, 59.3; H,
a)
A
mixture of the binuclear complex [{(h5-
C5Me5)MCl(m-Cl)}2] (0.08 mmol; Rh, 50 mg; Ir,
64 mg), NMe(PPh2)2 (64 mg; 0.16 mmol) and
NaBF4 (18 mg; 0.16 mmol) in C3H6O (20 ml) was
stirred for 1 h at r.t. The precipitated NaCl was
removed by filtration and the solution was evapo-
rated to a small volume. The complexes were
crystallised by careful addition of Et2O (5: yield:
109 mg, 90%; 6: yield: 135 mg, 84%).
1
5.4; N, 2.0%. H-NMR (CDCl3, 23 8C): d 1.67 [t, 15H,
C5Me5, 4J(PH)ꢀ
/
4.2 Hz], 2.91 [t, 3H, Me, 3J(PH)ꢀ
/
9.7
7.80 (m, 20H, Ph). 31P{1H}-NMR (CDCl3,
23 8C): d 66.9 [d, 1J(PRh)ꢀ
120 Hz]. FTIR (KBr,
CH3) 841 vs.
b) To a suspension of complex 3 or 4 (0.1 mmol) in
C3H8O (15 ml) was added AgBF4 (20 mg; 0.1
mmol). After stirring the mixture at r.t. for 1 h,
the solid AgCl formed was filtered off and the
solution evaporated to a small volume. The com-
plexes were precipitated by addition of Et2O (5:
Yield 72 mg, 95%; 6: Yield 78 mg, 92%).
Hz], 7.25ꢁ
/
/
cmꢃ1): n(CH, aliphatic) 2984 w, g(NÃ
/
Complex 2: Yield: 70 mg, 55%. Anal. Found: C, 52.8; H,
4.9; N, 1.8. C35H38Cl2IrNP2 requires: C, 52.7; H, 4.8; N,
1.8%. 1H-NMR (CDCl3, 23 8C): d 1.70 [t, 15H, C5Me5,
4J(PH)ꢀ
7.20ꢁ
d 33.5 [s]. FTIR (KBr, cmꢃ1): n(CH, aliphatic) 2914 w,
g(NÃCH3) 817 vs.
/
2.8 Hz], 2.92 [t, 3H, Me, J(PH)ꢀ
/10.1 Hz],
3
/
7.80 (m, 20H, Ph). 31P{1H}-NMR (CDCl3, 23 8C):
Complex 5: redꢁorange crystals. Anal. Found: C,
/
55.7; H, 5.1; N, 1.7. C35H38BClF4NP2Rh requires: C,
1
55.3; H, 5.0; N, 1.8%. H-NMR (CDCl3, 23 8C): d 1.63
/
1
For the iridium compound, the intermediate neutral complex [(h5-C5Me5)MCl{h2-P,P-(Ph2P)2N}] was obtained by evaporation of the
C6H5CH3 solution to a small volume and cooling to ꢃ20 8C [yield: 122 mg, 91%. Anal. Found: C, 53.8; H, 4.5; N, 1.8. C34H35ClIrNP2 requires: C,
54.6; H, 4.7; N, 1.9%. 1H-NMR (CDCl3, 23 8C): d 1.47 [t, 15H, C5Me5, 4J(PH)ꢀ 7.80 (m, 20H, Ph). 31P{1H}-NMR (CDCl3, 23 8C): d
2.5 Hz], 7.20ꢁ
25.08 (s)].
/
/
/
ꢃ/